[{"indications": "Indications\u00a0\n(From Hydroxycarbamide: British National Formulary)\nHydroxycarbamide; sickle-cell disease (%s\n(From HYDROXYCARBAMIDE: British National Formulary)\nHYDROXYCARBAMIDE)", "name": "HYDROXYCARBAMIDE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "8 Malignant disease and immunosuppression", "8.1 Cytotoxic drugs", "8.1.5 Other antineoplastic drugs", "Hydroxycarbamide", "HYDROXYCARBAMIDE"], "cautions": "Cautions\u00a0see section 8.1 and notes above; interactions: Appendix 1 (hydroxycarbamide)", "side-effects": "Side-effects\u00a0see section 8.1 and notes above", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/127938.htm", "doses": ["20\u201330\u00a0mg/kg daily or 80\u00a0mg/kg every third\r\nday"], "pregnancy": "Pregnancy\u00a0avoid (teratogenic in animal studies);\r\nmanufacturer advises effective contraception before and during treatment;\r\nsee also Pregnancy and Reproductive\r\nFunction"}, {"indications": "Indications\u00a0sickle-cell disease (\n(From Sickle-cell disease: British National Formulary)\nSickle-cell disease); chronic\r\nmyeloid leukaemia, cancer of the cervix (%s\n(From HYDROXYCARBAMIDE: British National Formulary)\nHYDROXYCARBAMIDE)", "name": "HYDROXYCARBAMIDE - SICKLE-CELL DISEASE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "9 Nutrition and blood", "9.1 Anaemias and some other blood disorders", "9.1.3 Drugs used in hypoplastic, haemolytic, and renal anaemias", "Sickle-cell disease", "HYDROXYCARBAMIDE"], "cautions": "Cautions\u00a0see section 8.1 and notes above; also monitor renal and hepatic function before and during treatment; monitor full blood count before treatment, then every\r\n2 weeks for the first 2 months and then every 2 months thereafter\r\n(or every 2 weeks if on max. dose); leg\r\nulcers (review treatment if cutaneous vasculitic\r\nulcerations develop); interactions: Appendix 1 (hydroxycarbamide)", "side-effects": "Side-effects\u00a0see section 8.1 and notes above; also\r\nheadache; less commonly dizziness and rash; rarely reduced sperm count and activity; fever, amenorrhoea,\r\nskin cancers (in elderly patients), bleeding and hypomagnesaemia also\r\nreported", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/202854.htm", "doses": ["By mouth, initially 15\u00a0mg/kg daily, increased\r\nevery 12 weeks in steps of 2.5\u20135\u00a0mg/kg daily according to response;\r\nusual dose 15\u201330\u00a0mg/kg daily (max. 35\u00a0mg/kg daily); child under 18 years, see BNF for Children"], "pregnancy": "Pregnancy\u00a0section 8.1.5"}, {"indications": "Indications\u00a0\n(From Hydroxycarbamide: British National Formulary)\nHydroxycarbamide; sickle-cell disease (%s\n(From HYDROXYCARBAMIDE: British National Formulary)\nHYDROXYCARBAMIDE)", "name": "HYDROXYCARBAMIDE - HYDROXYCARBAMIDE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "8 Malignant disease and immunosuppression", "8.1 Cytotoxic drugs", "8.1.5 Other antineoplastic drugs", "Hydroxycarbamide", "HYDROXYCARBAMIDE"], "cautions": "Cautions\u00a0see section 8.1 and notes above; interactions: Appendix 1 (hydroxycarbamide)", "side-effects": "Side-effects\u00a0see section 8.1 and notes above", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/127938.htm", "doses": ["20\u201330\u00a0mg/kg daily or 80\u00a0mg/kg every third\r\nday"], "pregnancy": "Pregnancy\u00a0avoid (teratogenic in animal studies);\r\nmanufacturer advises effective contraception before and during treatment;\r\nsee also Pregnancy and Reproductive\r\nFunction"}]